A
Clinician-reported breast lymphedema at 5 years
You're currently viewing OncGenius as a guest. To save your results, create an account or log in.
Advertisement
The nodal sub-study of the phase III FAST-Forward trial, published in Science Direct, investigated whether a 1-week schedule of 26 Gy in 5 fractions is safe for patients receiving adjuvant axillary radiotherapy for breast cancer.